Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis
Clinical Gastroenterology and Hepatology · 2025-08 · 23 (9) · 1514-1524.e13
DOI: 10.1016/j.cgh.2024.09.003 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Gastroenterology and Hepatology, 2025-08. Verfasst von Anne I Hahn und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: hahna1@mskcc.org. Hauptthemen laut MEDLINE: Disease Progression, Precancerous Conditions, Stomach Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
BACKGROUND & AIMS: Whether gastric cancer (GC) precursor lesions progress to invasive cancer at similar rates globally remains unknown. We conducted a systematic review and meta-analysis to determine the progression of precursor lesions to GC in countries with low versus medium/high incidence. METHODS: We searched relevant databases for studies reporting the progression of endoscopically confirmed precursor lesions to GC. Studies were stratified by low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: hahna1@mskcc.org.
- Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
- Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California.
- Weill Cornell Medical College of Cornell University, New York, New York.
- Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- NIDDK NIH HHS
- National Cancer Institute
- University College Dublin
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Hahn, A. I., Mülder, D. T., Huang, R. J., Zhou, M. J., Blake, B., Omofuma, O., Murphy, J. D., Gutiérrez-Torres, D. S., Zauber, A. G., O'Mahony, J. F., Camargo, M. C., Ladabaum, U., Yeh, J. M., Hur, C., Lansdorp-Vogelaar, I., Meester, R., & Laszkowska, M. (2025). Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 23(9), 1514-1524.e13. https://doi.org/10.1016/j.cgh.2024.09.003
Vancouver
Hahn AI, Mülder DT, Huang RJ, Zhou MJ, Blake B, Omofuma O, et al. Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 2025;23(9):1514-1524.e13. doi:10.1016/j.cgh.2024.09.003
BibTeX
@article{Hahn2025,
author = {Hahn, Anne I and Mülder, Duco T and Huang, Robert J and Zhou, Margaret J and Blake, Benjamin and Omofuma, Omonefe and Murphy, John D and Gutiérrez-Torres, Daniela S and Zauber, Ann G and O'Mahony, James F and Camargo, M Constanza and Ladabaum, Uri and Yeh, Jennifer M and Hur, Chin and Lansdorp-Vogelaar, Iris and Meester, Reinier and Laszkowska, Monika},
title = {Global Progression Rates of Precursor Lesions for Gastric Cancer: A Systematic Review and Meta-Analysis},
journal = {Clinical Gastroenterology and Hepatology},
year = {2025},
volume = {23},
number = {9},
pages = {1514--1524.e13},
doi = {10.1016/j.cgh.2024.09.003}
}
EUVIMED